NO174623C - Fremgangsmåte og fremstilling av 7-substituert hept-6-ensyre og heptansyrer og derivater derav - Google Patents
Fremgangsmåte og fremstilling av 7-substituert hept-6-ensyre og heptansyrer og derivater deravInfo
- Publication number
- NO174623C NO174623C NO902598A NO902598A NO174623C NO 174623 C NO174623 C NO 174623C NO 902598 A NO902598 A NO 902598A NO 902598 A NO902598 A NO 902598A NO 174623 C NO174623 C NO 174623C
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- preparation
- enoic acid
- heptanoic acids
- hept
- Prior art date
Links
- -1 7-substituted hept-6-enoic acid Chemical class 0.000 title 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical class C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 title 1
- 125000004185 ester group Chemical group 0.000 abstract 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- 241000845077 Iare Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000422 delta-lactone group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
- C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25747588A | 1988-10-13 | 1988-10-13 | |
| US35553189A | 1989-05-22 | 1989-05-22 | |
| PCT/EP1989/001201 WO1990003962A1 (en) | 1988-10-13 | 1989-10-11 | Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO902598D0 NO902598D0 (no) | 1990-06-12 |
| NO902598L NO902598L (no) | 1990-08-07 |
| NO174623B NO174623B (no) | 1994-02-28 |
| NO174623C true NO174623C (no) | 1994-06-08 |
Family
ID=26945992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO902598A NO174623C (no) | 1988-10-13 | 1990-06-12 | Fremgangsmåte og fremstilling av 7-substituert hept-6-ensyre og heptansyrer og derivater derav |
Country Status (24)
| Country | Link |
|---|---|
| EP (2) | EP0363934B1 (de) |
| JP (1) | JP2853227B2 (de) |
| KR (1) | KR0162656B1 (de) |
| AT (1) | ATE99281T1 (de) |
| AU (1) | AU636122B2 (de) |
| BG (1) | BG60555B1 (de) |
| CA (1) | CA2000553C (de) |
| CZ (1) | CZ283316B6 (de) |
| DE (1) | DE68911834T2 (de) |
| DK (1) | DK175073B1 (de) |
| ES (1) | ES2060712T3 (de) |
| FI (1) | FI98063C (de) |
| HK (1) | HK49496A (de) |
| HU (1) | HU207993B (de) |
| IE (2) | IE940109L (de) |
| IL (1) | IL91941A (de) |
| MY (1) | MY105067A (de) |
| NO (1) | NO174623C (de) |
| NZ (1) | NZ230973A (de) |
| RO (1) | RO109732B1 (de) |
| SG (1) | SG139553A1 (de) |
| SK (1) | SK280845B6 (de) |
| WO (1) | WO1990003962A1 (de) |
| YU (1) | YU48466B (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290946A (en) * | 1988-10-13 | 1994-03-01 | Sandoz Ltd. | Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes |
| US5118853A (en) * | 1988-10-13 | 1992-06-02 | Sandoz Ltd. | Processes for the synthesis of 3-disubstituted aminoacroleins |
| JPH03184961A (ja) * | 1989-10-10 | 1991-08-12 | Glaxo Group Ltd | 化合物 |
| DE4424525A1 (de) * | 1994-07-12 | 1995-01-26 | Elmar Meyer | Dauermagnet-Kolbenmotor |
| GT199800127A (es) | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. | |
| DK1216038T3 (da) | 1999-08-30 | 2005-12-27 | Sanofi Aventis Deutschland | Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser |
| CN1217930C (zh) | 2000-05-26 | 2005-09-07 | 西巴特殊化学品控股有限公司 | 吲哚衍生物的制备方法和该方法的中间体 |
| US7777006B2 (en) | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
| EP1623976A4 (de) * | 2003-04-24 | 2008-07-30 | Daicel Chem | Verfahren zur trennung optisch aktiver dihydroxyheptensäureester |
| US7368468B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| US7368581B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of fluvastatin sodium crystal from XIV |
| JP4037898B2 (ja) | 2003-06-18 | 2008-01-23 | テバ ファーマシューティカル インダストリーズ リミティド | フルバスタチンナトリウム結晶形xiv、lxxiii、lxxix、lxxx及びxxxvii型、それらの調製方法、それらを含有する組成物及びそれらの使用方法 |
| JP2007512347A (ja) | 2003-11-26 | 2007-05-17 | デューク・ユニバーシティー | 緑内障を予防するかまたは治療する方法 |
| US7851624B2 (en) | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| ATE431818T1 (de) | 2006-04-20 | 2009-06-15 | Italiana Sint Spa | Verfahren zur herstellung von fluvastatin-natrium |
| EP2327682A1 (de) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Verwendung von amphiphilen Verbindungen zur gesteuerten Kristallisation von Statinen und Statin Zwischenprodukte. |
| EP2373609B1 (de) | 2008-12-19 | 2013-10-16 | KRKA, D.D., Novo Mesto | Verwendung amphiphiler verbindungen zur kontrollierten kristallisation von statinen und statinzwischenprodukten |
| CN104902892A (zh) | 2012-02-02 | 2015-09-09 | 悉尼大学 | 泪液膜稳定性的改进 |
| EP2986599A1 (de) | 2013-04-17 | 2016-02-24 | Pfizer Inc. | N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| BR112021013807A2 (pt) | 2019-01-18 | 2021-11-30 | Astrazeneca Ab | Inibidores de pcsk9 e seus métodos de uso |
| WO2025168652A1 (en) | 2024-02-05 | 2025-08-14 | Astrazeneca Ab | Azd-0780 in combination with a statin for use in lowering ldl-c levels and treating cardiovacular diseases |
| TW202602886A (zh) | 2024-03-20 | 2026-01-16 | 瑞典商阿斯特捷利康公司 | Pcsk9抑制劑及其使用方法 |
| TW202602866A (zh) | 2024-03-20 | 2026-01-16 | 瑞典商阿斯特捷利康公司 | Pcsk9抑制劑及其使用方法 |
| TW202539678A (zh) | 2024-03-20 | 2025-10-16 | 瑞典商阿斯特捷利康公司 | Pcsk9抑制劑及其使用方法 |
| WO2025238159A1 (en) | 2024-05-16 | 2025-11-20 | Astrazeneca Ab | Combination therapy comprising azd0780 and ezetimibe |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB945536A (en) * | 1961-09-08 | 1964-01-02 | Istituto Chemioterapico | Method of preparing ª -amino-acroleins |
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| HU204253B (en) * | 1982-11-22 | 1991-12-30 | Sandoz Ag | Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them |
| US4571428A (en) * | 1983-07-08 | 1986-02-18 | Sandoz, Inc. | 6-Substituted-4-hydroxy-tetrahydropyran-2-ones |
| US4650890A (en) * | 1984-04-03 | 1987-03-17 | Sandoz Corp. | Preparation of olefinic compounds and intermediates thereof |
| ATE62906T1 (de) * | 1984-06-22 | 1991-05-15 | Sandoz Ag | Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung. |
| ATE60571T1 (de) * | 1984-12-04 | 1991-02-15 | Sandoz Ag | Inden-analoga von mevalonolakton und ihre derivate. |
| US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
| EP0244364A3 (de) * | 1986-04-30 | 1992-04-01 | Sandoz Ag | Herstellung von olefinischen Verbindungen |
| NZ221717A (en) * | 1986-09-10 | 1990-08-28 | Sandoz Ltd | Azaindole and indolizine derivatives and pharmaceutical compositions |
-
1989
- 1989-10-11 JP JP1510605A patent/JP2853227B2/ja not_active Expired - Lifetime
- 1989-10-11 AU AU43448/89A patent/AU636122B2/en not_active Expired
- 1989-10-11 IL IL9194189A patent/IL91941A/en not_active IP Right Cessation
- 1989-10-11 WO PCT/EP1989/001201 patent/WO1990003962A1/en not_active Ceased
- 1989-10-11 KR KR1019900701243A patent/KR0162656B1/ko not_active Expired - Lifetime
- 1989-10-11 MY MYPI89001403A patent/MY105067A/en unknown
- 1989-10-11 SG SG200602066-3A patent/SG139553A1/en unknown
- 1989-10-11 IE IE940109A patent/IE940109L/xx unknown
- 1989-10-11 EP EP89118906A patent/EP0363934B1/de not_active Expired - Lifetime
- 1989-10-11 HU HU896048A patent/HU207993B/hu unknown
- 1989-10-11 ES ES89118906T patent/ES2060712T3/es not_active Expired - Lifetime
- 1989-10-11 DE DE68911834T patent/DE68911834T2/de not_active Expired - Lifetime
- 1989-10-11 AT AT89118906T patent/ATE99281T1/de not_active IP Right Cessation
- 1989-10-11 EP EP19930106005 patent/EP0562643A3/en not_active Ceased
- 1989-10-11 IE IE327789A patent/IE63477B1/en not_active IP Right Cessation
- 1989-10-11 YU YU197389A patent/YU48466B/sh unknown
- 1989-10-11 NZ NZ230973A patent/NZ230973A/xx unknown
- 1989-10-11 RO RO145326A patent/RO109732B1/ro unknown
- 1989-10-12 SK SK5797-89A patent/SK280845B6/sk unknown
- 1989-10-12 CZ CS895797A patent/CZ283316B6/cs not_active IP Right Cessation
- 1989-10-12 CA CA002000553A patent/CA2000553C/en not_active Expired - Lifetime
-
1990
- 1990-06-07 BG BG92179A patent/BG60555B1/bg unknown
- 1990-06-12 NO NO902598A patent/NO174623C/no unknown
- 1990-06-12 FI FI902935A patent/FI98063C/fi active IP Right Grant
- 1990-06-13 DK DK199001446A patent/DK175073B1/da not_active IP Right Cessation
-
1996
- 1996-03-21 HK HK49496A patent/HK49496A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO174623C (no) | Fremgangsmåte og fremstilling av 7-substituert hept-6-ensyre og heptansyrer og derivater derav | |
| ES8103048A1 (es) | Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico. | |
| ES2066140T3 (es) | Derivados de acidos 7-ceto- y 7-hidroxi-androsta-3,5-dieno-3-carboxilicos. | |
| ES8706622A1 (es) | Procedimiento para preparar alfa-aminoacidos sustituidos | |
| ATE86960T1 (de) | Cyclopropanderivate. | |
| DK0619305T3 (da) | Lactonforbindelse og fremgangsmåde til fremstilling deraf | |
| GB1514389A (en) | Glycerides with antibacterial properties | |
| ES2006361A6 (es) | Un procedimiento para preparar derivados de insoindolinilo opticamente activos. | |
| UA3421C1 (uk) | Спосіб одержання похідних 2-тіазолідінону | |
| DK0574185T3 (da) | PGE,-analog | |
| GR1000469B (el) | Mεθοδος παρασκευης κινολινοκαρβοξυλικων οξεων. | |
| CA1273347C (de) | ||
| BG49274A3 (bg) | Метод за получаване на естери на l-аминодикарбонова киселина | |
| RU94045824A (ru) | Способ получения 3-карбониландростадиен-17-карбоксамидов | |
| NO920441L (no) | Tnf-inhibitorer | |
| FI894424A0 (fi) | Acylderivat av dianhydrohexitoler. | |
| PT91980A (pt) | Processo para a preparacao de acidos hept-6-enoicos e heptanoicos substituidos na posicao 7 e seus derivados e produtos intermediarios | |
| DE58909563D1 (de) | 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren | |
| DE58909745D1 (de) | Tetrahydro-4-phenylimino-3-thiophenessigsäuren | |
| GR1000201B (el) | Mέ?οδος για την παρασκευή του 1-κυκλοπροπυλο-6-φ?ορο-1,4-διϋδρο-4-οξο-7κινολίνο-3-καρβοξυλικού οξέος δομικού λί?ου παρασκευής των 1-κυκλοπρόπυλο-6-φ?όρο-1,4-διϋδρο-4οξο-7-πιπεράζινο-κινολινο 3καρβοξυλικών οξέων. |